CT textural analysis of gastric cancer: correlations with immunohistochemical biomarkers

[1]  Mohammad Hossein Khosravi,et al.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 , 2018, JAMA oncology.

[2]  M. Naghavi,et al.  Exclusion of Kaposi Sarcoma From Analysis of Cancer Burden-Reply. , 2017, JAMA oncology.

[3]  Perry J Pickhardt,et al.  CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[4]  Jian He,et al.  Application of CT texture analysis in predicting histopathological characteristics of gastric cancers , 2017, European Radiology.

[5]  M. Anzidei,et al.  Analysis of CT features and quantitative texture analysis in patients with lung adenocarcinoma: a correlation with EGFR mutations and survival rates. , 2017, Clinical radiology.

[6]  Francesco Giganti,et al.  Pre-treatment MDCT-based texture analysis for therapy response prediction in gastric cancer: Comparison with tumour regression grade at final histology. , 2017, European journal of radiology.

[7]  Francesco Giganti,et al.  Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker , 2017, European Radiology.

[8]  Alan D. Lopez,et al.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study , 2017, JAMA oncology.

[9]  Kui-Sheng Chen,et al.  Spectral computed tomography in advanced gastric cancer: Can iodine concentration non-invasively assess angiogenesis? , 2017, World journal of gastroenterology.

[10]  Sang Joon Park,et al.  Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. , 2016, European journal of radiology.

[11]  F. Roviello,et al.  Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer. , 2016, Cancer letters.

[12]  Richard D. White,et al.  CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung. , 2015, AJR. American journal of roentgenology.

[13]  Alejandro Munoz del Rio,et al.  CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes , 2015, Abdominal Imaging.

[14]  Nicola Schieda,et al.  Can Quantitative CT Texture Analysis be Used to Differentiate Fat-poor Renal Angiomyolipoma from Renal Cell Carcinoma on Unenhanced CT Images? , 2015, Radiology.

[15]  Y. Doki,et al.  Accuracy of multidetector-row CT in diagnosing lymph node metastasis in patients with gastric cancer , 2015, European Radiology.

[16]  R. Thornhill,et al.  Quantitative CT texture and shape analysis: Can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? , 2015, European Radiology.

[17]  S. Kobayashi,et al.  Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data. , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[18]  Xin He,et al.  Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis , 2014, BMC Cancer.

[19]  C. Fuchs,et al.  Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial , 2014, The Lancet.

[20]  V. Goh,et al.  Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. , 2013, Radiology.

[21]  H. Honda,et al.  Extent of arterial tumor enhancement measured with preoperative MDCT gastrography is a prognostic factor in advanced gastric cancer after curative resection. , 2013, AJR. American journal of roentgenology.

[22]  Yongfei Wang,et al.  The prognostic value of E‐cadherin in gastric cancer: A meta‐analysis , 2013, International journal of cancer.

[23]  Z. Chang,et al.  Relationship between expression of EGFR in gastric cancer tissue and clinicopathological features. , 2013, Asian Pacific journal of tropical medicine.

[24]  Vicky Goh,et al.  Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? , 2013, European journal of radiology.

[25]  Z. Wang,et al.  Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  R. Wirtz,et al.  The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer , 2012, BMC Cancer.

[27]  R. Sutradhar,et al.  A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer , 2012, Gastric Cancer.

[28]  Dan Zhou,et al.  [Correlation of CT presentation with histo-differentiation and p53 and Ki67 expressions in gastric cancer]. , 2011, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[29]  E. Fishman,et al.  Hypervascular gastric masses: CT findings and clinical correlates. , 2010, AJR. American journal of roentgenology.

[30]  Yihong Sun,et al.  Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis. , 2010, World journal of gastroenterology.

[31]  W. Kim,et al.  Low Ki‐67 proliferation index is an indicator of poor prognosis in gastric cancer , 2010, Journal of surgical oncology.

[32]  Y. Yatabe,et al.  Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer , 2010, The FEBS journal.

[33]  F. Schmidt.  Meta-Analysis , 2008 .

[34]  P. Kim,et al.  Gastric cancer staging at multi-detector row CT gastrography: comparison of transverse and volumetric CT scanning. , 2005, Radiology.

[35]  M. Huang,et al.  Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. , 2003, Cancer letters.

[36]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[37]  Y. Saito,et al.  Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma. , 2000, Gynecologic oncology.

[38]  Gerhard Christofori,et al.  A causal role for E-cadherin in the transition from adenoma to carcinoma , 1998, Nature.

[39]  L. Ellis,et al.  Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  J. Gerdes.  Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. , 1990, Seminars in cancer biology.

[41]  F. Giganti,et al.  Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography , 2015, Gastric Cancer.

[42]  Jie Ma,et al.  Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer , 2014, Medical Oncology.

[43]  V. Goh,et al.  Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. , 2013, Radiology.